Physician Assistant, Medical · Glen Mills, PA
NPI
1295885168
Since 2007
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1020 Baltimore Pike Ste 310
Glen Mills, PA, 19342
Phone (484) 227-7532
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,426
97 services
Medicare patients, 2024
96
Average age 75
Drug cost, 2024
$4.1M
1,183 prescriptions
Company payments, 2025
$122K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jacqueline Kernaghan was code 99214 (office e&m - established), 58 times for 58 patients. In total Jacqueline Kernaghan billed 97 services in 3 codes, and Medicare paid $4,426.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 58 | 58 | $44.36 | $2,573 |
| 99213 Office E&M - Established | Office | 28 | 28 | $33.96 | $951 |
| 99215 Office E&M - Established | Office | 11 | 11 | $81.98 | $902 |
By year: 2022 $16K for 242 services; 2023 $7,175 for 81 services; 2024 $4,426 for 97 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jacqueline Kernaghan prescribed most often to Medicare patients was Tymlos (Abaloparatide), with 451 prescriptions and refills. In total Jacqueline Kernaghan wrote 1,183 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tymlos Abaloparatide | 451 | 464 | 76 | $1.2M |
| Teriparatide Generic | 186 | 197 | 35 | $432K |
| Raloxifene Hcl Generic | 172 | 479 | 61 | $10K |
| Hydrochlorothiazide Generic | 80 | 241 | 31 | $384 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 55 | 116 | 31 | $2,169 |
| Chlorthalidone Generic | 37 | 111 | 15 | $891 |
| Forteo Teriparatide | 21 | 25 | Under 11 | $109K |
| Prolia Denosumab | 19 | 114 | 17 | $32K |
| Estradiol (Twice Weekly) Estradiol | 16 | 45 | Under 11 | $1,463 |
| Strensiq Asfotase Alfa | 16 | 17 | Under 11 | $2.2M |
| Progesterone Progesterone, Micronized | 15 | 41 | Under 11 | $943 |
| Risedronate Sodium Generic | 13 | 32 | Under 11 | $934 |
| Evenity (2 Syringes) Romosozumab-Aqqg | 11 | 11 | Under 11 | $27K |
Brand drugs: 708 claims; generic drugs: 379 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jacqueline Kernaghan $122K ($122K in general payments such as food, travel and fees) from 7 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $66K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.